**Author details**

Peter Magnusson1,2

1 Cardiology Research Unit, Department of Medicine, Karolinska Institute, Sweden

2 Centre for Research and Development, Uppsala University, Gävleborg, Gävle, Sweden

\*Address all correspondence to: peter.magnusson@regiongavleborg.se

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**5**

*Introductory Chapter: Aortic Stenosis*

**References**

*DOI: http://dx.doi.org/10.5772/intechopen.86521*

[1] Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, et al. Focus update on the echocardiographic assessment of aortic valve stenosis: EAE/ASE recommendations for clinical practice. European Heart Journal Cardiovascular [7] Clavel MA, Malouf J, Michelena HI, Suri RM, Jaffe AS, Mahoney DW, et al. B-type natriuretic peptide clinical activation in aortic stenosis: Impact on long-term survival. Journal of the American College of Cardiology.

[8] Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. The New England Journal of Medicine.

[9] Genereux P, Stone GW, O'Gara PT, Marquis-Gravel G, Redfors B, Giustino G, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. Journal of the American College of Cardiology.

[10] Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. European Heart Journal.

[11] Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. PARTNER trial investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. The New England Journal of Medicine.

[12] Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, et al. CoreValve US clinical

investigators. 3-year outcomes in highrisk patients who underwent surgical or transcatheter aortic valve replacement. Journal of the American College of Cardiology. 2016;**67**:2565-2574

[13] Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk

2014;**63**:2016-2025

2000;**343**:611-617

2016;**67**:2263-2288

2005;**26**:1309-1313

2010;**363**:1597-1607

[2] Cueff C, Serfaty JM, Cimadevilla C, Laissy JP, Himbert D, Tubach F, et al. Measurement of aortic valve calcification using multislice computed tomography: Correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction.

[3] Clavel MA, Messika-Zeitoun D, Pibarot P, Aggarwal SR, Malouf J, Araoz PA, et al. The complex nature of discordant severe calcified aortic valve disease grading: New insights from combined Doppler echocardiographic and computed tomographic study. Journal of the American College of Cardiology. 2013;**62**:2329-2338

[4] Rafique AM, Biner S, Ray I, Forrester JS, Tolstrup K, Siegel RJ. Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis. The American Journal of

[5] Marechaux S, Hachicha Z, Bellouin A, Dumesnil JG, Meimoun P, Pasquet A, et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. European Heart

Cardiology. 2009;**104**:972-977

Journal. 2010;**31**:1390-1397

2004;**109**:2302-2308

[6] Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation.

Imaging. 2017;**18**:254-275

Heart. 2011;**97**:721-726

*Introductory Chapter: Aortic Stenosis DOI: http://dx.doi.org/10.5772/intechopen.86521*
